Cost considerations for systemic therapy for patients with advanced genitourinary malignancies-Reference-Cited by-同舟云学术

Cost considerations for systemic therapy for patients with advanced genitourinary malignancies

Published:2018-03-26 Issue:14 Volume:124 Page:2897-2905
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Henry Mark A.¹,Leung Andrew¹,Filson Christopher P.¹^ORCID

Affiliation:

1. Department of Urology; Emory University School of Medicine; Atlanta Georgia

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference72 articles.

1. Centers for Medicare and Medicaid Services NHE Fact Sheet https://www.cms.gov/research-statistics-data-and-systems/statistics-trends-and-reports/nationalhealthexpenddata/nhe-fact-sheet.html 2017

2. Updating cost-effectiveness-the curious resilience of the $50,000-per-QALY threshold;Neumann;N Engl J Med,2014

3. Increasing incidence of metastatic prostate cancer in the United States (2004-2013);Weiner;Prostate Cancer Prostatic Dis,2016

4. Increase in prostate cancer distant metastases at diagnosis in the United States;Hu;JAMA Oncol,2017

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient Preferences for Attributes of Androgen Deprivation Therapies in Prostate Cancer: A Discrete Choice Experiment with Latent Class Analysis;Advances in Therapy;2024-08-21

2. Evaluating Financial Toxicity in Urologic Practice;Urology;2023-09

3. The cost burden of metastatic prostate cancer in the US populations covered by employer‐sponsored health insurance;Cancer;2023-06-17

4. The Cost of Metastatic Prostate Cancer in the United States;Urology Practice;2023-01

5. Bilateral Orchidectomy Revisited in Management of Metastatic Hormone-Sensitive Prostate Cancer;Indian Journal of Surgical Oncology;2021-07-24